US Stock MarketDetailed Quotes

TOI The Oncology Institute

Watchlist
  • 1.1400
  • 0.00000.00%
Close Mar 31 16:00 ET
  • 1.1400
  • 0.00000.00%
Post 16:05 ET
100.05MMarket Cap-1.61P/E (TTM)

The Oncology Institute Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
26.92%-26.54M
207.53%4.19M
109.86%819K
-80.83%-15.66M
-2.79%-15.88M
41.20%-36.32M
72.19%-3.89M
59.26%-8.31M
16.56%-8.66M
9.00%-15.45M
Net income from continuing operations
22.16%-64.66M
29.71%-13.18M
7.50%-16.11M
8.39%-15.48M
33.70%-19.89M
-54,750.00%-83.07M
-70.38%-18.75M
-551.42%-17.42M
-209.87%-16.9M
-255.54%-30M
Operating gains losses
-389.55%-3.05M
-96.98%44K
-128.62%-571K
-311.38%-2.53M
100.35%12K
97.63%-622K
114.46%1.46M
113.00%2M
70.22%-615K
-367.88%-3.46M
Depreciation and amortization
7.05%6.29M
8.24%1.71M
-7.36%1.57M
14.22%1.52M
17.34%1.49M
33.14%5.87M
32.30%1.58M
49.74%1.7M
21.04%1.33M
28.57%1.27M
Deferred tax
--0
--0
--0
--0
--0
71.10%-76K
71.75%-126K
53.85%80K
91.84%-4K
-114.44%-26K
Other non cash items
16.72%6.31M
2.11%1.59M
106.67%2.14M
-50.22%1.01M
102.20%1.56M
109.52%5.4M
140.63%1.56M
138.49%1.04M
118.84%2.04M
101.95%771K
Change In working capital
665.54%18.06M
97.55%12.73M
1,131.77%11.46M
-289.12%-3.41M
42.81%-2.73M
111.48%2.36M
223.53%6.45M
85.38%-1.11M
564.58%1.8M
40.24%-4.78M
-Change in receivables
-28.28%-5.77M
54.24%6.18M
75.90%-493K
1,040.91%4.76M
-172.46%-16.22M
77.13%-4.5M
178.12%4.01M
66.74%-2.05M
86.26%-506K
-26.58%-5.95M
-Change in inventory
182.99%3.64M
104.55%67K
20,366.67%1.22M
112.12%232K
313.90%2.12M
-153.18%-4.39M
-272.77%-1.47M
99.29%-6K
-377.31%-1.91M
25.45%-993K
-Change in prepaid assets
-62.40%1.18M
196.00%1.18M
-93.89%100K
-53.27%521K
-2,520.83%-629K
-26.95%3.13M
-45.73%400K
-31.59%1.64M
60.20%1.12M
-105.26%-24K
-Change in payables and accrued expense
129.02%18.69M
49.07%5.4M
1,953.56%10.42M
-365.56%-8.85M
562.80%11.73M
319.62%8.16M
247.11%3.62M
73.97%-562K
-0.24%3.33M
172.59%1.77M
-Change in other current assets
-41.30%3.36M
-4.20%1.3M
-107.35%-97K
-75.81%410K
29.33%1.75M
9.05%5.72M
-18.65%1.36M
-10.45%1.32M
44.38%1.7M
45.01%1.35M
-Change in other current liabilities
47.44%-3.03M
4.99%-1.39M
122.01%320K
75.08%-479K
-59.76%-1.48M
-16.32%-5.77M
-65.05%-1.46M
36.95%-1.45M
-124.53%-1.92M
-1.98%-927K
Cash from discontinued investing activities
Operating cash flow
26.92%-26.54M
207.53%4.19M
109.86%819K
-80.83%-15.66M
-2.79%-15.88M
41.20%-36.32M
72.19%-3.89M
59.26%-8.31M
16.56%-8.66M
9.00%-15.45M
Investing cash flow
Cash flow from continuing investing activities
-26.23%46.21M
-115.09%-1.76M
34.93%10.4M
-27.01%18.18M
5.36%19.39M
147.59%62.64M
135.70%11.63M
108.78%7.71M
342.67%24.9M
1,936.43%18.4M
Net PPE purchase and sale
17.04%-3.79M
-103.83%-1.76M
143.23%402K
-94.88%-1.83M
66.83%-610K
17.40%-4.57M
56.84%-861K
21.85%-930K
30.18%-937K
-83.53%-1.84M
Net business purchase and sale
--0
--0
--0
----
----
48.05%-4.46M
66.81%-156K
--0
----
----
Net investment purchase and sale
-30.23%50M
--0
15.75%10M
-33.64%20M
-1.20%20M
160.99%71.66M
142.00%12.64M
109.88%8.64M
--30.14M
--20.24M
Cash from discontinued investing activities
Investing cash flow
-26.23%46.21M
-115.09%-1.76M
34.93%10.4M
-27.01%18.18M
5.36%19.39M
147.59%62.64M
135.70%11.63M
108.78%7.71M
342.67%24.9M
1,936.43%18.4M
Financing cash flow
Cash flow from continuing financing activities
49.00%-3.49M
90.79%-164K
67.86%-243K
17.45%-2.15M
45.11%-938K
-107.43%-6.85M
-110.27%-1.78M
-100.72%-756K
75.66%-2.6M
-3.14%-1.71M
Net issuance payments of debt
61.39%-39K
0.00%-10K
-10.00%-11K
85.71%-9K
50.00%-9K
-100.09%-101K
47.37%-10K
-100.01%-10K
-384.62%-63K
-38.46%-18K
Net common stock issuance
--0
--0
--0
----
----
88.68%-1.02M
--0
---125K
----
----
Proceeds from stock option exercised by employees
-40.48%75K
--0
--0
--2K
--73K
-85.31%126K
-74.43%113K
-83.54%13K
--0
--0
Net other financing activities
39.72%-3.53M
91.83%-154K
63.41%-232K
-30.17%-2.14M
40.75%-1M
38.99%-5.85M
-48.35%-1.88M
86.43%-634K
18.17%-1.64M
-2.86%-1.69M
Cash from discontinued financing activities
Financing cash flow
49.00%-3.49M
90.79%-164K
67.86%-243K
17.45%-2.15M
45.11%-938K
-107.43%-6.85M
-110.27%-1.78M
-100.72%-756K
75.66%-2.6M
-3.14%-1.71M
Net cash flow
Beginning cash position
139.03%33.49M
72.15%47.4M
26.07%36.42M
136.43%36.06M
139.03%33.49M
-87.84%14.01M
-55.17%27.54M
-55.00%28.89M
-84.04%15.25M
-87.84%14.01M
Current changes in cash
-16.93%16.18M
-61.92%2.27M
908.99%10.98M
-97.30%369K
107.02%2.57M
119.25%19.48M
112.56%5.95M
51.24%-1.36M
143.55%13.64M
106.31%1.24M
End cash Position
48.32%49.67M
48.32%49.67M
72.15%47.4M
26.07%36.42M
136.43%36.06M
139.03%33.49M
139.03%33.49M
-55.17%27.54M
-55.00%28.89M
-84.04%15.25M
Free cash flow
25.82%-30.33M
151.14%2.43M
113.21%1.22M
-82.20%-17.49M
4.62%-16.49M
39.24%-40.88M
70.27%-4.75M
57.20%-9.24M
18.12%-9.6M
3.85%-17.29M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 26.92%-26.54M207.53%4.19M109.86%819K-80.83%-15.66M-2.79%-15.88M41.20%-36.32M72.19%-3.89M59.26%-8.31M16.56%-8.66M9.00%-15.45M
Net income from continuing operations 22.16%-64.66M29.71%-13.18M7.50%-16.11M8.39%-15.48M33.70%-19.89M-54,750.00%-83.07M-70.38%-18.75M-551.42%-17.42M-209.87%-16.9M-255.54%-30M
Operating gains losses -389.55%-3.05M-96.98%44K-128.62%-571K-311.38%-2.53M100.35%12K97.63%-622K114.46%1.46M113.00%2M70.22%-615K-367.88%-3.46M
Depreciation and amortization 7.05%6.29M8.24%1.71M-7.36%1.57M14.22%1.52M17.34%1.49M33.14%5.87M32.30%1.58M49.74%1.7M21.04%1.33M28.57%1.27M
Deferred tax --0--0--0--0--071.10%-76K71.75%-126K53.85%80K91.84%-4K-114.44%-26K
Other non cash items 16.72%6.31M2.11%1.59M106.67%2.14M-50.22%1.01M102.20%1.56M109.52%5.4M140.63%1.56M138.49%1.04M118.84%2.04M101.95%771K
Change In working capital 665.54%18.06M97.55%12.73M1,131.77%11.46M-289.12%-3.41M42.81%-2.73M111.48%2.36M223.53%6.45M85.38%-1.11M564.58%1.8M40.24%-4.78M
-Change in receivables -28.28%-5.77M54.24%6.18M75.90%-493K1,040.91%4.76M-172.46%-16.22M77.13%-4.5M178.12%4.01M66.74%-2.05M86.26%-506K-26.58%-5.95M
-Change in inventory 182.99%3.64M104.55%67K20,366.67%1.22M112.12%232K313.90%2.12M-153.18%-4.39M-272.77%-1.47M99.29%-6K-377.31%-1.91M25.45%-993K
-Change in prepaid assets -62.40%1.18M196.00%1.18M-93.89%100K-53.27%521K-2,520.83%-629K-26.95%3.13M-45.73%400K-31.59%1.64M60.20%1.12M-105.26%-24K
-Change in payables and accrued expense 129.02%18.69M49.07%5.4M1,953.56%10.42M-365.56%-8.85M562.80%11.73M319.62%8.16M247.11%3.62M73.97%-562K-0.24%3.33M172.59%1.77M
-Change in other current assets -41.30%3.36M-4.20%1.3M-107.35%-97K-75.81%410K29.33%1.75M9.05%5.72M-18.65%1.36M-10.45%1.32M44.38%1.7M45.01%1.35M
-Change in other current liabilities 47.44%-3.03M4.99%-1.39M122.01%320K75.08%-479K-59.76%-1.48M-16.32%-5.77M-65.05%-1.46M36.95%-1.45M-124.53%-1.92M-1.98%-927K
Cash from discontinued investing activities
Operating cash flow 26.92%-26.54M207.53%4.19M109.86%819K-80.83%-15.66M-2.79%-15.88M41.20%-36.32M72.19%-3.89M59.26%-8.31M16.56%-8.66M9.00%-15.45M
Investing cash flow
Cash flow from continuing investing activities -26.23%46.21M-115.09%-1.76M34.93%10.4M-27.01%18.18M5.36%19.39M147.59%62.64M135.70%11.63M108.78%7.71M342.67%24.9M1,936.43%18.4M
Net PPE purchase and sale 17.04%-3.79M-103.83%-1.76M143.23%402K-94.88%-1.83M66.83%-610K17.40%-4.57M56.84%-861K21.85%-930K30.18%-937K-83.53%-1.84M
Net business purchase and sale --0--0--0--------48.05%-4.46M66.81%-156K--0--------
Net investment purchase and sale -30.23%50M--015.75%10M-33.64%20M-1.20%20M160.99%71.66M142.00%12.64M109.88%8.64M--30.14M--20.24M
Cash from discontinued investing activities
Investing cash flow -26.23%46.21M-115.09%-1.76M34.93%10.4M-27.01%18.18M5.36%19.39M147.59%62.64M135.70%11.63M108.78%7.71M342.67%24.9M1,936.43%18.4M
Financing cash flow
Cash flow from continuing financing activities 49.00%-3.49M90.79%-164K67.86%-243K17.45%-2.15M45.11%-938K-107.43%-6.85M-110.27%-1.78M-100.72%-756K75.66%-2.6M-3.14%-1.71M
Net issuance payments of debt 61.39%-39K0.00%-10K-10.00%-11K85.71%-9K50.00%-9K-100.09%-101K47.37%-10K-100.01%-10K-384.62%-63K-38.46%-18K
Net common stock issuance --0--0--0--------88.68%-1.02M--0---125K--------
Proceeds from stock option exercised by employees -40.48%75K--0--0--2K--73K-85.31%126K-74.43%113K-83.54%13K--0--0
Net other financing activities 39.72%-3.53M91.83%-154K63.41%-232K-30.17%-2.14M40.75%-1M38.99%-5.85M-48.35%-1.88M86.43%-634K18.17%-1.64M-2.86%-1.69M
Cash from discontinued financing activities
Financing cash flow 49.00%-3.49M90.79%-164K67.86%-243K17.45%-2.15M45.11%-938K-107.43%-6.85M-110.27%-1.78M-100.72%-756K75.66%-2.6M-3.14%-1.71M
Net cash flow
Beginning cash position 139.03%33.49M72.15%47.4M26.07%36.42M136.43%36.06M139.03%33.49M-87.84%14.01M-55.17%27.54M-55.00%28.89M-84.04%15.25M-87.84%14.01M
Current changes in cash -16.93%16.18M-61.92%2.27M908.99%10.98M-97.30%369K107.02%2.57M119.25%19.48M112.56%5.95M51.24%-1.36M143.55%13.64M106.31%1.24M
End cash Position 48.32%49.67M48.32%49.67M72.15%47.4M26.07%36.42M136.43%36.06M139.03%33.49M139.03%33.49M-55.17%27.54M-55.00%28.89M-84.04%15.25M
Free cash flow 25.82%-30.33M151.14%2.43M113.21%1.22M-82.20%-17.49M4.62%-16.49M39.24%-40.88M70.27%-4.75M57.20%-9.24M18.12%-9.6M3.85%-17.29M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Precision Drilling
PDS
+2.78%
Lantheus
LNTH
+1.50%
eBay
EBAY
+0.85%
DexCom
DXCM
+0.81%
Collegium Pharmaceutical
COLL
+0.47%

Unlock the Full List